If you liked this article you might like

Alexion Pharma, Still Recovering From Boardroom Troubles, Appoints New CEO
Biotech Stock Mailbag: Sage Therapeutics, Cellceutix, Alzheimer's Risk
Nektar Addiction-Resistant Opioid Reduces Chronic Pain in Late-Stage Study
Amgen Cholesterol Drug Cuts Risk of Heart Attack, Stroke but Not Enough to Quell Value Debate